SI-BONE CFO sells shares to cover RSU taxes
SI-BONE, Inc. Chief Financial Officer Anshul Maheshwari reported two open-market sales of common stock that were executed solely to cover tax withholding from vested restricted stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SI-BONE, Inc. Chief Financial Officer Anshul Maheshwari reported two open-market sales of common stock that were executed solely to cover tax withholding from vested restricted stock units. The transactions totaled 4,666 shares, sold at weighted average prices of $14.6545 and $14.7132 per share.
A footnote explains these were mandatory "sell to cover" trades and not discretionary sales. Another footnote notes 1,395 shares acquired under the 2018 Employee Stock Purchase Plan and 183,921 shares issuable upon settlement of outstanding restricted stock units, indicating a substantial remaining equity position tied to future vesting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,477 | $14.7132 | $36K |
| Sale | Common Stock | 2,189 | $14.6545 | $32K |
Footnotes (4)
- F1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- F2. This transaction was executed in multiple trades at prices ranging from $14.35 USD to $14.84 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. Includes 1,395 shares acquired under the SI-BONE, Inc 2018 Employee Stock Purchase Plan on May 15, 2026.
- F4. Includes 183,921 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Key Figures
Key Terms
sell to cover financial
restricted stock units financial
weighted average sale price financial
Employee Stock Purchase Plan financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SI-BONE (SIBN) report for its CFO?
Were the SI-BONE (SIBN) CFO’s stock sales discretionary or pre-arranged?
What ongoing equity exposure does the SI-BONE (SIBN) CFO retain?
AI-generated analysis. How Rhea-AI works. Not financial advice.